These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21425211)

  • 1. MicroRNAs in inflammatory bowel disease.
    Pekow JR; Kwon JH
    Inflamm Bowel Dis; 2012 Jan; 18(1):187-93. PubMed ID: 21425211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.
    Iborra M; Bernuzzi F; Invernizzi P; Danese S
    Autoimmun Rev; 2012 Mar; 11(5):305-14. PubMed ID: 20627134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.
    Soroosh A; Koutsioumpa M; Pothoulakis C; Iliopoulos D
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G256-G262. PubMed ID: 29146677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
    Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
    World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
    Xu XM; Zhang HJ
    World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
    Lin L; Zhou G; Chen P; Wang Y; Han J; Chen M; He Y; Zhang S
    Cell Death Dis; 2020 Jun; 11(6):456. PubMed ID: 32541691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Boros É; Nagy I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
    Fisher K; Lin J
    World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNAs and inflammatory bowel disease: An interesting new story.
    Moein S; Vaghari-Tabari M; Qujeq D; Majidinia M; Nabavi SM; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3277-3293. PubMed ID: 30417350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of microRNAs in inflammatory bowel disease.
    Jung H; Kim JS; Lee KH; Tizaoui K; Terrazzino S; Cargnin S; Smith L; Koyanagi A; Jacob L; Li H; Hong SH; Yon DK; Lee SW; Kim MS; Wasuwanich P; Karnsakul W; Shin JI; Kronbichler A
    Int J Biol Sci; 2021; 17(8):2112-2123. PubMed ID: 34131410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.
    De Iudicibus S; Lucafò M; Martelossi S; Pierobon C; Ventura A; Decorti G
    World J Gastroenterol; 2013 Nov; 19(44):7947-54. PubMed ID: 24307788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
    Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: how many in inflammatory bowel disease?
    Schaefer JS
    Curr Opin Gastroenterol; 2016 Jul; 32(4):258-66. PubMed ID: 27138057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of inflammatory bowel disease-associated miRNAs using a novel bipartite clustering approach.
    Altaf-Ul-Amin M; Karim MB; Hu P; Ono N; Kanaya S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):10. PubMed ID: 32093721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: new players in IBD.
    Kalla R; Ventham NT; Kennedy NA; Quintana JF; Nimmo ER; Buck AH; Satsangi J
    Gut; 2015 Mar; 64(3):504-17. PubMed ID: 25475103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
    Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease.
    Xiao X; Mao X; Chen D; Yu B; He J; Yan H; Wang J
    Front Immunol; 2022; 13():868229. PubMed ID: 35493445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.
    Zhang L; Cheng J; Fan XM
    World J Gastroenterol; 2014 May; 20(19):5818-25. PubMed ID: 24914342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.
    Tomankova T; Petrek M; Gallo J; Kriegova E
    Scand J Immunol; 2012 Feb; 75(2):129-41. PubMed ID: 21988491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.